Poseida Therapeutics Inc (PSTX)
2.73
+0.02
(+0.74%)
USD |
NASDAQ |
Nov 22, 16:00
2.86
+0.13
(+4.76%)
After-Hours: 20:00
Poseida Therapeutics Market Cap: 266.08M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 266.08M |
| November 21, 2024 | 264.13M |
| November 20, 2024 | 265.10M |
| November 19, 2024 | 269.98M |
| November 18, 2024 | 260.23M |
| November 15, 2024 | 269.00M |
| November 14, 2024 | 312.86M |
| November 13, 2024 | 319.69M |
| November 12, 2024 | 359.65M |
| November 11, 2024 | 361.60M |
| November 08, 2024 | 300.19M |
| November 07, 2024 | 285.57M |
| November 06, 2024 | 270.95M |
| November 05, 2024 | 259.26M |
| November 04, 2024 | 246.59M |
| November 01, 2024 | 240.74M |
| October 31, 2024 | 230.87M |
| October 30, 2024 | 231.84M |
| October 29, 2024 | 238.66M |
| October 28, 2024 | 241.58M |
| October 25, 2024 | 234.76M |
| October 24, 2024 | 235.74M |
| October 23, 2024 | 243.53M |
| October 22, 2024 | 243.53M |
| October 21, 2024 | 243.53M |
| Date | Value |
|---|---|
| October 18, 2024 | 238.66M |
| October 17, 2024 | 247.43M |
| October 16, 2024 | 247.43M |
| October 15, 2024 | 247.43M |
| October 14, 2024 | 243.53M |
| October 11, 2024 | 244.50M |
| October 10, 2024 | 240.61M |
| October 09, 2024 | 249.37M |
| October 08, 2024 | 250.35M |
| October 07, 2024 | 259.11M |
| October 04, 2024 | 254.24M |
| October 03, 2024 | 247.43M |
| October 02, 2024 | 257.17M |
| October 01, 2024 | 267.88M |
| September 30, 2024 | 278.60M |
| September 27, 2024 | 281.69M |
| September 26, 2024 | 288.49M |
| September 25, 2024 | 291.40M |
| September 24, 2024 | 299.17M |
| September 23, 2024 | 300.14M |
| September 20, 2024 | 327.34M |
| September 19, 2024 | 350.65M |
| September 18, 2024 | 340.94M |
| September 17, 2024 | 328.31M |
| September 16, 2024 | 291.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
117.26M
Minimum
May 11 2022
1.005B
Maximum
Jul 20 2020
385.39M
Average
324.25M
Median
Jul 11 2024
Market Cap Benchmarks
| Organogenesis Holdings Inc | 536.93M |
| MaxCyte Inc | 374.46M |
| NovaBay Pharmaceuticals Inc | 3.327M |
| Palatin Technologies Inc | 18.77M |
| iBio Inc | 24.15M |
Market Cap Related Metrics
| PS Ratio | 1.751 |
| Price to Book Value | 3.051 |
| Price | 2.73 |
| Earnings Yield | -22.71% |